Multifocal electroretinographic responses in sector retinitis pigmentosa.


Journal

International ophthalmology
ISSN: 1573-2630
Titre abrégé: Int Ophthalmol
Pays: Netherlands
ID NLM: 7904294

Informations de publication

Date de publication:
Mar 2020
Historique:
received: 31 07 2019
accepted: 16 11 2019
pubmed: 24 11 2019
medline: 29 1 2021
entrez: 24 11 2019
Statut: ppublish

Résumé

Multifocal electroretinography (mfERG) may be useful in the management of sector retinitis pigmentosa (SRP). To compare multifocal electroretinographic responses in SRP, generalised retinitis pigmentosa (GRP), and healthy controls. Eighteen patients with SRP, twelve with GRP, and fifteen controls were included in the study. All participants underwent: complete ophthalmological examination, Humphrey visual field testing, full-field ERG, and mfERG. The mean P1 amplitude, the implicit time (IT), and the mapping of the local responses were evaluated. The mean P1 amplitude was higher in the SRPs than in GRPs (p < 0.001), while it did not differ between SRPs and controls (p = 0.913). In the SRPs, the P1 amplitude in pathologic areas was higher than in the GRPs (p < 0.001). In normal areas, this parameter did not differ from the controls (p = 0.499). Moreover, in the SRPs, no differences in the P1 amplitude and the IT between pigmented and non-pigmented areas were found. In the present study, the mfERG examination displayed significant differences between sector and generalised RP, showing normal values in sector RP even in pigmented areas. Considering the patients included in this study, SRP seems to represent a favourable variant of the disease, characterised by a limited retinal involvement and apparently mild functional damage. It is still unclear how these results can be extended to other forms of SRP.

Identifiants

pubmed: 31758507
doi: 10.1007/s10792-019-01231-4
pii: 10.1007/s10792-019-01231-4
doi:

Types de publication

Comparative Study Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

703-708

Références

Acta Ophthalmol Scand. 2004 Dec;82(6):701-6
pubmed: 15606467
Doc Ophthalmol. 2003 Mar;106(2):171-81
pubmed: 12678282
Ophthalmology. 2002 Mar;109(3):560-8
pubmed: 11874762
Am J Ophthalmol. 1988 Feb 15;105(2):132-40
pubmed: 3341429
Vision Res. 1998 Jan;38(1):163-79
pubmed: 9474387
Retina. 2006 Feb;26(2):248-50
pubmed: 16467695
Klin Oczna. 1990 Jul;92(1-2):28-30
pubmed: 2266695
Ophthalmologe. 2001 Mar;98(3):294-9
pubmed: 11320819
Doc Ophthalmol. 2012 Feb;124(1):1-13
pubmed: 22038576
Optometry. 2005 May;76(5):309-17
pubmed: 15884421
Wien Klin Wochenschr. 1986 May 2;98(9):264-9
pubmed: 3727597
Jpn J Ophthalmol. 1987;31(3):327-48
pubmed: 2448510
Arch Ophthalmol. 1985 Apr;103(4):524-8
pubmed: 3985831
Doc Ophthalmol. 1993;85(2):95-114
pubmed: 8082549
Prog Retin Eye Res. 2000 Sep;19(5):607-46
pubmed: 10925245
Ophthalmic Res. 1998;30(1):1-10
pubmed: 9483582
Am J Ophthalmol. 1998 Feb;125(2):214-26
pubmed: 9467449
Am J Ophthalmol. 1970 Jun;69(6):977-87
pubmed: 5423778
Nippon Ganka Gakkai Zasshi. 1992 Feb;96(2):243-50
pubmed: 1558022
Int Ophthalmol. 1981 Aug;4(1-2):7-22
pubmed: 7028651
Ophthalmic Physiol Opt. 1998 Jul;18(4):335-50
pubmed: 9829106
Br J Ophthalmol. 2006 Apr;90(4):472-9
pubmed: 16547330
Invest Ophthalmol Vis Sci. 1995 Sep;36(10):2146-50
pubmed: 7657552

Auteurs

Barbara Giambene (B)

Al Emadi Hospital, Doha, Qatar.

Tommaso Verdina (T)

Institute of Ophthalmology, University of Modena and Reggio Emilia, Via del Pozzo 71, 41100, Modena, Italy. tommaso.verdina@gmail.com.

Monica Pennino (M)

Ophthalmology Department, Azienda Ospedaliero-Universitaria Careggi, Florence, Italy.

Monica Fabbrucci (M)

Ophthalmology Department, Azienda Ospedaliero-Universitaria Careggi, Florence, Italy.

Gian Maria Cavallini (GM)

Institute of Ophthalmology, University of Modena and Reggio Emilia, Via del Pozzo 71, 41100, Modena, Italy.

Ugo Menchini (U)

Ophthalmology Department, Azienda Ospedaliero-Universitaria Careggi, Florence, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH